drug · small molecule
COMETRIQ
updated 5mo agoby $EXEL EXELIXIS, INC.🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 8- drugcabozantinib s-malate97 co-mentions · 25 sources
- drugCABOMETYX97 co-mentions · 25 sources
- tagApproval96 co-mentions · 24 sources
- tagSmall Molecule48 co-mentions · 24 sources
- drugcabozantinib48 co-mentions · 24 sources
- tagOncology2 co-mentions · 1 sources
- company$TAKTAKEDA PHARMACEUTICAL CO LTD1 co-mentions · 1 sources
- company$TKPHFTAKEDA PHARMACEUTICAL CO LTD1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 9 investigational indications.
targets
Hepatocyte growth factor receptorVascular endothelial growth factor receptor 2
all catalysts(0)
nothing on the calendar yet
Trials studying COMETRIQ
News(1)
- BioNTech sets survival standard in hard-to-treat cancer ahead of pivotal readoutBioNTech has linked gotistobart to a median overall survival of 18.5 months in relapsed lung cancer patients, adding to evidence that the anti-CTLA-4 antibody is better than the standard of care.fiercebiotech · 18d ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that